AlanLouisSchneiderMDDABPM

Addiction, Geriatric Psychiatry, Psychopharmacology

Medical Director Aetna/CVS HealthCare

Dr. Schneider is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1151 Dove St
Ste 100
Newport Beach, CA 92660
Phone+1 818-472-1132

Fax+1 818-786-0530

Currently, I am a Senior Medical Director of Aetna/CVS overseeing Addiction Medicine treatment and fraud recovery.I also maintain a private practice in psychotherapy and psychopharmacology.I have spent the past 35 years in a dual career of administrative medicine,research and clinical psychopharmacology. I have spent some 14 years in phase 1 through 3 clinical trial testing of agents for depression/anxiety/dementia/migraine/parkinsons/ schizophrenia/bipolar disorder. For 12 years I did research in TMS. I am now involved in TMS research on addictive disorders.
I continue to serve as an expert reviewer for the California Medical Board and the US Department of Justice, and do consultant quality assurance work .
I have continued to publish articles in pharmacology

Duke University HospitalFellowship, Transcranial Magnetic Stimulation, ECT, 1999 - 1999
UCLA David Geffen School of Medicine/UCLA Medical Center/VA Greater Los Angeles Healthcare SystemResidency, Psychiatry, 1987 - 1988
Cedars-Sinai Medical CenterResidency, Psychiatry, 1986 - 1987
Cedars-Sinai Medical CenterResidency, Psychiatry, 1984 - 1985
Cedars-Sinai Medical CenterInternship, Internal Medicine, 1983 - 1984
Keck School of Medicine of the University of Southern CaliforniaClass of 1983

PubMed

122 citations
Developing a practical suicide risk prediction model for targeting high‐risk patients in the Veterans health Administration
Ronald C. Kessler, Irving Hwang, Claire A. Hoffmire, John F. McCarthy, Maria Petukhova
International Journal of Methods in Psychiatric Research. 2017-07-04
51 citations
Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: a 4-week randomized placebo controlled study.
Alan L. Schneider, Terry L. Schneider, Harry Stark
Brain Stimulation. 2008-04-01
8 citations
Risks and Benefits of Rapid Clozapine Titration.
Jeannie D Lochhead, Michele A Nelson, Alan L. Schneider
Mental Illness. 2016-05-18

Journal Articles

The Bidirectionality of Attention-Deficit, Hyperactivity Disorder and Adverse Childhood Experiences: A Review
Tsai, R. Schneider,A., Psychology and Psychiatry, 5/5/2022
A case of Letrozole induced mania
Schneider ,A, Bipolar Disorders, 3/23/2001

4 week placebo controlled study of rTMS in negative symptoms of schizopreniaStanley Foundation2000–2004
4 week placebo controlled study of rTMS in negative symptoms of SchizophreniaNARSAD2000–2004
Ronald Reagan Research Award in Alzheimers DiseaseAlzheimers Association2000–2004